Cargando…
Botulinum toxin type A for neuropathic pain in patients with spinal cord injury
OBJECTIVE: To evaluate the analgesic effect of botulinum toxin type A (BTX‐A) on patients with spinal cord injury‐associated neuropathic pain. METHODS: The effect of BTX‐A on 40 patients with spinal cord injury‐associated neuropathic pain was investigated using a randomized, double‐blind, placebo‐co...
Autores principales: | Han, Zee‐A, Song, Dae Heon, Oh, Hyun‐Mi, Chung, Myung Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825405/ https://www.ncbi.nlm.nih.gov/pubmed/26814620 http://dx.doi.org/10.1002/ana.24605 |
Ejemplares similares
-
Botulinum Toxin for Neuropathic Pain: A Review of the Literature
por: Oh, Hyun-Mi, et al.
Publicado: (2015) -
Botulinum Toxin for Central Neuropathic Pain
por: Park, Jihye, et al.
Publicado: (2018) -
Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins
por: Oh, Hyun-Mi, et al.
Publicado: (2015) -
Botulinum Toxin for the Treatment of Neuropathic Pain
por: Park, JungHyun, et al.
Publicado: (2017) -
A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury
por: Li, Gang, et al.
Publicado: (2017)